| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/27/2000 | EP1038525A1 Stable drug composition |
| 09/27/2000 | EP1038524A1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof |
| 09/27/2000 | EP1038523A2 Method for identifying compounds for inhibition of neoplastic lesions |
| 09/27/2000 | EP1038522A2 Anticonvulsant enantiomeric amino acid derivatives |
| 09/27/2000 | EP1038520A1 Cosmetics containing meclofenoxate |
| 09/27/2000 | EP1038519A1 Use of at least a grafted silicone polymer as a tensioner |
| 09/27/2000 | EP1038515A1 Composition having an aqueous phase containing l-2-oxothiazolidine-4-carboxylic acid |
| 09/27/2000 | EP1038027A1 Decreasing cell proliferation by decreasing levels of pp5 |
| 09/27/2000 | EP1038023A1 Agonists of metabotropic glutamate receptors and uses thereof |
| 09/27/2000 | EP1038019A1 NOVEL ribB |
| 09/27/2000 | EP1038016A2 Needle-free injection of formulated nucleic acid molecules |
| 09/27/2000 | EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/27/2000 | EP1037994A1 Peptide antagonists of vascular endothelial growth factor |
| 09/27/2000 | EP1037993A2 A new gene called oligophrenin 1, its expression product, and the diagnostic and therapeutic applications thereof |
| 09/27/2000 | EP1037985A1 Restin and methods of use thereof |
| 09/27/2000 | EP1037984A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 09/27/2000 | EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 09/27/2000 | EP1037929A1 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 09/27/2000 | EP1037926A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 09/27/2000 | EP1037915A1 Matrix-remodeling genes |
| 09/27/2000 | EP1037905A1 Antipicornaviral compounds and methods for their use and preparation |
| 09/27/2000 | EP1037894A1 Pharmaceuticals |
| 09/27/2000 | EP1037892A1 Piperidine derivatives |
| 09/27/2000 | EP1037890A1 Amino-benzothiazole derivatives |
| 09/27/2000 | EP1037889A1 Novel compounds |
| 09/27/2000 | EP1037888A1 ($i(E))-3- 1-$i(N)-BUTYL- 5- 2-(2-CARBOXYPHENYL)METHOXY- 4-CHLOROPHENYL]-1$i(H)- PYRAZOL-4-YL]-2- (5- METHOXY-2,3- DIHYDROBENZOFURAN-6-YL)METHYL]- PROP-2-ENOIC ACID MONOARGININYL SALT |
| 09/27/2000 | EP1037887A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 09/27/2000 | EP1037886A1 Triazine angiogenesis inhibitors |
| 09/27/2000 | EP1037883A1 NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 09/27/2000 | EP1037880A1 Retinoic acid mimetic anilides |
| 09/27/2000 | EP1037878A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
| 09/27/2000 | EP1037876A1 Biphenyl derivatives as pharmaceuticals |
| 09/27/2000 | EP1037874A1 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 09/27/2000 | EP1037871A1 Novel antiarrhythmic compounds |
| 09/27/2000 | EP1037868A2 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 09/27/2000 | EP1037666A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 09/27/2000 | EP1037662A1 Method to enhance an immune response of nucleic acid vaccination |
| 09/27/2000 | EP1037661A1 ribH |
| 09/27/2000 | EP1037660A1 ribB |
| 09/27/2000 | EP1037654A1 ribA |
| 09/27/2000 | EP1037642A1 Modified polysaccharides exhibiting altered biological recognition |
| 09/27/2000 | EP1037640A2 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 09/27/2000 | EP1037639A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| 09/27/2000 | EP1037638A1 Agents |
| 09/27/2000 | EP1037637A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy |
| 09/27/2000 | EP1037636A1 Inhibition of membrane-associated viral replication |
| 09/27/2000 | EP1037635A1 Compounds and methods |
| 09/27/2000 | EP1037634A1 Novel administration form comprising an acid-labile active compound |
| 09/27/2000 | EP1037633A1 Antiviral compounds |
| 09/27/2000 | EP1037630A2 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
| 09/27/2000 | EP1037629A2 Combination of a retinoic acid metabolism blocking agent and a tocophereol |
| 09/27/2000 | EP1037628A1 Methods for preventing restenosis using tocotrienols |
| 09/27/2000 | EP1037627A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 09/27/2000 | EP1037626A1 Multicatalytic protease inhibitors for use as anti-tumor agents |
| 09/27/2000 | EP1037625A1 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 09/27/2000 | EP1037624A1 Methods and compositions for treating diabetes |
| 09/27/2000 | EP1037623A1 Antihyperlipidemic statin-lp(a) inhibitor combinations |
| 09/27/2000 | EP1037622A1 Taurine derivatives usable in the treatment of ophthalmic disorders |
| 09/27/2000 | EP1037621A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 09/27/2000 | EP1037620A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
| 09/27/2000 | EP1037619A2 Selected c 10? perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 09/27/2000 | EP1037618A1 Use of nucleosides, nucleobases and their derivatives for reducing the thrombocytopenic side effects of cytostatic agents |
| 09/27/2000 | EP1037617A1 Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease |
| 09/27/2000 | EP1037616A2 Combination of alpha-adrenergic blockers and cgmp levels-elevating compounds effective for the treatment of impotence |
| 09/27/2000 | EP1037615A2 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 09/27/2000 | EP1037614A2 A double capsule for the administration of active principles in multiple therapies |
| 09/27/2000 | EP1037612A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 09/27/2000 | EP1037611A1 Biodegradable mixed polymeric micelles for gene delivery |
| 09/27/2000 | EP1037610A1 Liposomal camptothecin formulations |
| 09/27/2000 | EP1037609A1 Aqueous insecticidal pour-on formulation |
| 09/27/2000 | EP1037607A1 Novel suppository form comprising an acid-labile active compound |
| 09/27/2000 | EP1037605A1 Local delivery of therapeutic agents |
| 09/27/2000 | EP1037604A1 Pharmaceutical aerosol compositions |
| 09/27/2000 | EP1037597A1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 09/27/2000 | EP1037596A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 09/27/2000 | EP1037590A2 Soy formulations and their use for promoting health |
| 09/27/2000 | EP1037588A2 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation |
| 09/27/2000 | EP1037534A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
| 09/27/2000 | EP1037531A1 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 09/27/2000 | EP1037529A1 Composition useful for providing one-step surgical preparation and drape |
| 09/27/2000 | EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor |
| 09/27/2000 | EP0901465B1 Compounds with anti-inflammatory and immunosuppressive activities |
| 09/27/2000 | EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 09/27/2000 | EP0848703B1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
| 09/27/2000 | EP0773947B1 5H-THIAZOLO 3,2-a]PYRIMIDIN-5-ONE DERIVATIVES |
| 09/27/2000 | EP0767842B1 Methods of screening for nucleoside analogs that are incorporated by hiv reverse transcriptase and cause incorrect base pairing |
| 09/27/2000 | EP0733052B1 Bicyclene derivatives, their production and use |
| 09/27/2000 | EP0703915B1 Xamoneline tartrate |
| 09/27/2000 | EP0612216B1 Phospholipid antimicrobial compositions |
| 09/27/2000 | EP0575484B1 Composition comprising pdgf and dexamethasone for promoting tissue repair and regeneration |
| 09/27/2000 | CN1268186A i (in vivo) use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes |
| 09/27/2000 | CN1268140A Monocyclic L-nucleosides, analogs and uses thereof |
| 09/27/2000 | CN1268138A Compounds |
| 09/27/2000 | CN1268137A Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 09/27/2000 | CN1268136A Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
| 09/27/2000 | CN1268135A Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 09/27/2000 | CN1268134A Bis-indole derivatives having antimetastatic activity, A process for their preparation and pharmaceutical compositions containing them |
| 09/27/2000 | CN1268133A 2-Aminopyridines containing fused ring substituents as NOS inhibitors |
| 09/27/2000 | CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 09/27/2000 | CN1268126A Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors |